[1]
2024. Drug‐Associated Nephrotic Syndrome: A Global Pharmacovigilance Perspective. Portuguese Kidney Journal. 38, 3-4 (Dec. 2024), 140–149. DOI:https://doi.org/10.71749/pkj.42.